Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19227 | 515 | 26.5 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
613 | 3 | GOUT//HYPERURICEMIA//URIC ACID | 14056 |
1622 | 2 | GOUT//HYPERURICEMIA//URIC ACID | 7034 |
19227 | 1 | TUMOR LYSIS SYNDROME//RASBURICASE//TUMOUR LYSIS SYNDROME | 515 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TUMOR LYSIS SYNDROME | authKW | 7206136 | 32% | 74% | 165 |
2 | RASBURICASE | authKW | 4098240 | 17% | 80% | 86 |
3 | TUMOUR LYSIS SYNDROME | authKW | 1185797 | 6% | 67% | 30 |
4 | TUMOR LYSIS | authKW | 726296 | 4% | 58% | 21 |
5 | ACUTE TUMOR LYSIS SYNDROME | authKW | 539006 | 2% | 91% | 10 |
6 | SPONTANEOUS TUMOR LYSIS SYNDROME | authKW | 533618 | 2% | 100% | 9 |
7 | RECOMBINANT URATE OXIDASE | authKW | 363155 | 1% | 88% | 7 |
8 | TUMOR LYSIS SYNDROME TLS | authKW | 363155 | 1% | 88% | 7 |
9 | HYPERURICEMIA | authKW | 305044 | 14% | 7% | 70 |
10 | URATE OXIDASE | authKW | 235179 | 4% | 21% | 19 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 2045 | 33% | 0% | 172 |
2 | Hematology | 1990 | 19% | 0% | 100 |
3 | Urology & Nephrology | 638 | 11% | 0% | 56 |
4 | Medicine, General & Internal | 596 | 17% | 0% | 87 |
5 | Pediatrics | 587 | 12% | 0% | 64 |
6 | Pharmacology & Pharmacy | 73 | 10% | 0% | 49 |
7 | Emergency Medicine | 54 | 2% | 0% | 8 |
8 | Medical Laboratory Technology | 53 | 2% | 0% | 10 |
9 | Nursing | 32 | 2% | 0% | 9 |
10 | Transplantation | 28 | 2% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AF EMATOL | 59291 | 0% | 100% | 1 |
2 | BUNKYO J KU | 59291 | 0% | 100% | 1 |
3 | CATEDRA TRATAMIENTO INTENS | 59291 | 0% | 100% | 1 |
4 | CHILDRENS HOSP NEW YORK P BYTERIAN PHARM | 59291 | 0% | 100% | 1 |
5 | HARPER HOSP MED | 59291 | 0% | 100% | 1 |
6 | HEMATOL ONCOLHEMATOL MALIGNANCIES PROGRAM | 59291 | 0% | 100% | 1 |
7 | HOT DIEU UNIV HOSP | 59291 | 0% | 100% | 1 |
8 | KLIN UROL NEFROL | 59291 | 0% | 100% | 1 |
9 | LEUKEMIA LYMPHONA MYELOMA PROGRAMHERBERT IRVIN | 59291 | 0% | 100% | 1 |
10 | MAYWOOD EDWARD J HINES VET ADM HOSP | 59291 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MEDICAL AND PEDIATRIC ONCOLOGY | 1908 | 2% | 0% | 9 |
2 | CONTRIBUTIONS TO NEPHROLOGY | 1885 | 1% | 0% | 7 |
3 | PEDIATRIC NEPHROLOGY | 1168 | 2% | 0% | 11 |
4 | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 985 | 1% | 0% | 6 |
5 | ANNALS OF PHARMACOTHERAPY | 879 | 2% | 0% | 9 |
6 | SEMINARS IN INTERVENTIONAL RADIOLOGY | 775 | 1% | 0% | 3 |
7 | LEUKEMIA & LYMPHOMA | 765 | 2% | 0% | 10 |
8 | EUROPEAN JOURNAL OF HAEMATOLOGY | 750 | 1% | 0% | 7 |
9 | CLINICAL LYMPHOMA & MYELOMA | 730 | 0% | 1% | 2 |
10 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 709 | 1% | 0% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TUMOR LYSIS SYNDROME | 7206136 | 32% | 74% | 165 | Search TUMOR+LYSIS+SYNDROME | Search TUMOR+LYSIS+SYNDROME |
2 | RASBURICASE | 4098240 | 17% | 80% | 86 | Search RASBURICASE | Search RASBURICASE |
3 | TUMOUR LYSIS SYNDROME | 1185797 | 6% | 67% | 30 | Search TUMOUR+LYSIS+SYNDROME | Search TUMOUR+LYSIS+SYNDROME |
4 | TUMOR LYSIS | 726296 | 4% | 58% | 21 | Search TUMOR+LYSIS | Search TUMOR+LYSIS |
5 | ACUTE TUMOR LYSIS SYNDROME | 539006 | 2% | 91% | 10 | Search ACUTE+TUMOR+LYSIS+SYNDROME | Search ACUTE+TUMOR+LYSIS+SYNDROME |
6 | SPONTANEOUS TUMOR LYSIS SYNDROME | 533618 | 2% | 100% | 9 | Search SPONTANEOUS+TUMOR+LYSIS+SYNDROME | Search SPONTANEOUS+TUMOR+LYSIS+SYNDROME |
7 | RECOMBINANT URATE OXIDASE | 363155 | 1% | 88% | 7 | Search RECOMBINANT+URATE+OXIDASE | Search RECOMBINANT+URATE+OXIDASE |
8 | TUMOR LYSIS SYNDROME TLS | 363155 | 1% | 88% | 7 | Search TUMOR+LYSIS+SYNDROME+TLS | Search TUMOR+LYSIS+SYNDROME+TLS |
9 | HYPERURICEMIA | 305044 | 14% | 7% | 70 | Search HYPERURICEMIA | Search HYPERURICEMIA |
10 | URATE OXIDASE | 235179 | 4% | 21% | 19 | Search URATE+OXIDASE | Search URATE+OXIDASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CRISCUOLO, M , FIANCHI, L , DRAGONETTI, G , PAGANO, L , (2016) TUMOR LYSIS SYNDROME: REVIEW OF PATHOGENESIS, RISK FACTORS AND MANAGEMENT OF A MEDICAL EMERGENCY.EXPERT REVIEW OF HEMATOLOGY. VOL. 9. ISSUE 2. P. 197 -208 | 82 | 89% | 1 |
2 | FIRWANA, BM , HASAN, R , HASAN, N , ALAHDAB, F , ALNAHHAS, I , HASAN, S , VARON, J , (2012) TUMOR LYSIS SYNDROME: A SYSTEMATIC REVIEW OF CASE SERIES AND CASE REPORTS.POSTGRADUATE MEDICINE. VOL. 124. ISSUE 2. P. 92 -101 | 84 | 85% | 8 |
3 | WILSON, FP , BERNS, JS , (2014) TUMOR LYSIS SYNDROME: NEW CHALLENGES AND RECENT ADVANCES.ADVANCES IN CHRONIC KIDNEY DISEASE. VOL. 21. ISSUE 1. P. 18-26 | 65 | 83% | 11 |
4 | WILSON, FP , BERNS, JS , (2012) ONCO-NEPHROLOGY: TUMOR LYSIS SYNDROME.CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. VOL. 7. ISSUE 10. P. 1730 -1739 | 64 | 82% | 18 |
5 | HORL, WH , (2005) TUMOR LYSES SYNDROME: RISK FACTORS AND THERAPY.WIENER KLINISCHE WOCHENSCHRIFT. VOL. 117. ISSUE 1-2. P. 7 -17 | 83 | 81% | 2 |
6 | BURNS, RA , TOPOZ, I , REYNOLDS, SL , (2014) TUMOR LYSIS SYNDROME RISK FACTORS, DIAGNOSIS, AND MANAGEMENT.PEDIATRIC EMERGENCY CARE. VOL. 30. ISSUE 8. P. 571 -579 | 53 | 93% | 0 |
7 | DAVIDSON, MB , THAKKAR, S , HIX, JK , BHANDARKAR, ND , WONG, A , SCHREIBER, MJ , (2004) PATHOPHYSIOLOGY, CLINICAL CONSEQUENCES, AND TREATMENT OF TUMOR LYSIS SYNDROME.AMERICAN JOURNAL OF MEDICINE. VOL. 116. ISSUE 8. P. 546-554 | 53 | 93% | 139 |
8 | MALAGUARNERA, G , GIORDANO, M , MALAGUARNERA, M , (2012) RASBURICASE FOR THE TREATMENT OF TUMOR LYSIS IN HEMATOLOGICAL MALIGNANCIES.EXPERT REVIEW OF HEMATOLOGY. VOL. 5. ISSUE 1. P. 27 -38 | 63 | 74% | 4 |
9 | COIFFIER, B , ALTMAN, A , PUI, CH , YOUNES, A , CAIRO, MS , (2008) GUIDELINES FOR THE MANAGEMENT OF PEDIATRIC AND ADULT TUMOR LYSIS SYNDROME: AN EVIDENCE-BASED REVIEW.JOURNAL OF CLINICAL ONCOLOGY. VOL. 26. ISSUE 16. P. 2767-2778 | 35 | 97% | 175 |
10 | GEMICI, C , (2006) TUMOUR LYSIS SYNDROME IN SOLID TUMOURS.CLINICAL ONCOLOGY. VOL. 18. ISSUE 10. P. 773-780 | 49 | 94% | 29 |
Classes with closest relation at Level 1 |